USFDA classifies Jubilant Pharmova’s API Facility as VAI

08 Mar 2023 Evaluate

Jubilant Pharmova has received a communication from the United States Food and Drug Administration (USFDA) through which the regulatory agency assigned the inspection classification of the API facility as Voluntary Action Indicated (VAI). USFDA had inspected its API manufacturing facility at Nanjangud during December 05, 2022 to December 13, 2022.

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP).

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×